Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression

Surgery Today

Volumn 36, Issue 12, 2006, Pages 1039-1046

  Kohri, Takayuki ^a,b,d   Sugano, Masayuki ^c   Kawashima, Osamu ^c   Saito, Ryusei ^c   Sakurai, Shinji ^a   Sano, Takaaki ^a   Nakajima, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tone Central Hospital   (Japan)

^c National Nishigunma Hospital   (Japan)

^d NONE   (Japan)

Author keywords

Discriminant analysis; Immunohistochemistry; Lung cancer; Prognosis; Tissue microarray

Indexed keywords

BETA CATENIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN 1; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; SCATTER FACTOR RECEPTOR; THYROID TRANSCRIPTION FACTOR 1; UVOMORULIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; LUNG NON SMALL CELL CANCER; MALE; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE MICROARRAY;

ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; DISCRIMINANT ANALYSIS; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33751439552     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-006-3319-1     Document Type: Article

References (33)

1. Oshima A, Kuroishi T, Tajima K. Gan Toukei Hakusyo 2004: Tokyo, Japan. Shinohara Shuppanshinsya; 2004, p. 51-9
2. T Morita 2002 A statistical study of lung cancer in the annual of pathological autopsy cases in Japan from 1958 to 1997, with reference to time trends of lung cancer in the world Jpn J Cancer Res 93 15 23
3. AF Gazdar RI Linnoila 1988 The pathology of lung cancer-changing concepts and newer diagnostic techniques Semin Oncol 15 215 25
4. Y Watanabe 2003 TNM classification for lung cancer Ann Thorac Surg 9 343 50
5. T Shirakusa K Kobayashi 2002 Lung cancer in Japan: Analysis of lung cancer registry for resected cases in 1994 JJLC 42 555 66
6. J Niklinski W Niklinska J Laudanski E Chyczewska L Chyczewski 2001 Prognostic molecular markers in non-small cell lung cancer Lung Cancer 34 53 8
7. E Steels M Paesmans T Berghmans F Branle F Lemaitre C Mascaux 2001 Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 18 705 19
8. INK4A, pRB and p53 J Surg. Oncol 81 177 84
9. T Shoji F Tanaka T Takaka K Ynangihara Y Otake H Hanaoka 2002 Clinical significance of p21 expression in non-small-cell lung cancer J Clin Oncol 20 3865 71
10. J Marc D Yudong 2002 A gene expression signature as a predictor of survival in breast cancer N Engl J Med 25 1999 2009
11. MB Eisen PT Spellman PO Brown D Botstein 1998 Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 14863 8
12. G Sherlock 2000 Analysis of large-scale gene expression date Curr Opin Immunol 12 201 5
13. J Kononen L Bubendorf A Kallioniemi 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 7
14. M Milanes-Yearsley EH Hammond TF Pajak JS Cooper C Chang T Griffin 2002 Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups Mod Pathol 15 1366 73
15. MA Rubin R Dunn M Strawderman KJ Pienta 2002 Tissue micro-array sampling strategy for prostate cancer biomarker analysis Am J Surg Pathol 347 312 9
16. NHC Au M Cheang DG Huntsman E Yorida A Coldman WM Elliott 2004 Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers J Pathol 204 101 9
17. M Nakashima K Sonoda T Watanabe 1999 Inhibitor of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 Nat Med 5 938 42
18. T Kaku K Sonoda T Kamura T Hirakawa K Sakai S Amada 1999 The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix Clin Cancer Res 5 1449 53
19. S Oizumi K Yamazaki M Nakashima T Watanabe F Hommura S Ogura 2002 RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung Oncology 62 333 9
20. T Iwasaki M Nakashima T Watanabe S Yamamoto Y Inoue H Yamanaka 2000 Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1 Int J Cancer 89 488 93
21. M Izumi Y Nakanishi I Yoshino M Nakashima T Watanabe N Hara 2001 Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in non-small cell lung carcinoma Cancer 92 446 51
22. D Fabbro C di Loreto O Stamerra CA Beltrami R Lonigro G Damante 1996 TTF-1 gene expression in human lung tumors Eur J Cancer 32A 512 17
23. PA Bejarano RP Baughman PW Biddinger MA Miller C Fenoglio-Preiser B Al-Kafaji 1995 Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas Mod Pathol 9 445 52
24. C Di Loreto V Di Lauro F Puglisi G Damante D Fabbro CA Beltrami 1997 Immunocytochemical expression of tissue-specific transcription factor-1 in lung carcinoma J Clin Pathol 50 30 3
25. RS Saad YL Liu H Han RJ Landreneau JF Silverman 2004 Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung Hum Pathol 35 3 7
26. F Puglish F Barbone G Damante M Bruckbauer VD Lauro CA Beltrami 1999 Prognostic value of thyroid transcription factor-1 in primary resected non-small cell lung carcinoma Mod Pathol 12 318 24
27. PC Ma G Maulik J Christensen R Salgia 2003 c-Met: structure, functions and potential for therapeutic inhibition Cancer Metastasis Rev 22 309 25
28. M Jeffers S Rong GF Woude 1996 Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis J Mol Med 74 505 13
29. JM Siegfried LA Weissfeld JD Luketich RJ Weyant CT Gubish RJ Landreneau 1998 The clinical significance of hepatocyte growth factor for non-small lung cancer Ann Thorac Surg 66 1915 18
30. D Masuya C Huang D Liu T Nakashima K Kameyama R Hara 2004 The tumor-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumor growth and prognosis in non-small-cell lung cancer patients Br J Cancer 90 1555 62
31. I Takanami F Tanana T Hashizume K Kikuchi T Yamamoto S Kodaira 1996 Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers Oncology 53 392 7
32. P Winkel BE Statland 1990 Multivariate techniques to assess laboratory tests in cancer patients Immunol Ser 53 27 38
33. L Ju-Seog ST Snorri 2004 Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets Gastroenterology 127 suppl 1 S51 5